Evidence map›Paper›PMID 36499227›Full record

ArticleInternational journal of molecular sciences2022

A Discovery-Based Metabolomic Approach Using UPLC-Q-TOF-MS/MS Reveals Potential Antimalarial Compounds Present in

Henan Shi, Zhuqing Wang, Fujie Xu, Jialin Li, Jing Li, Manyuan Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Enhanced Antimalarial Activity of Extracts ofChem & bio engineering · 2024
    Article
  7. Five DifferentInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Henan ShiBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Zhuqing WangBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Fujie XuBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Jialin LiBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Jing LiBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Manyuan WangBeijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Capital Medical University · CN

Funding

Major National Science and Technology Program of China for Innovative Drug 2017ZX09101002-001-002National Natural Science Foundation of China Nos. 81102752National Natural Science Foundation of China Nos. 81841001
6 · The paper itself

Abstract

In 1972, Nobel laureate Youyou Tu's research team conducted clinical trials on the dried material of

Indexed as

AntimalarialsArtemisia annuaFolic Acid AntagonistsSesquiterpenesAnimalsArtemisininsEtherFlavonoidsMicePlant ExtractsTandem Mass SpectrometryAntimalarialsartemisininArtemisininsEtherFlavonoidsFolic Acid AntagonistsPlant ExtractsSesquiterpenesantimalarialArtemisia annua L.OPLS-DAsynergistic effectUPLC-Q-TOF-MS

Identifiers

PMID36499227
PMCPMC9740527
OpenAlexW4310154741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.